1. "2024"
Formats
  1. Journal Article (2329)
  2. Meeting Abstract (1694)
  3. Review (589)
  4. Editorial (305)
  5. Book Section (98)
  6. Correspondence (92)
  7. Guidelines (90)
  8. Research Letter (89)
  9. Miscellaneous (55)
  10. Conference Paper (33)
  11. Book Whole (3)
Groups
  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)

More Groups

People
  1. Eileen O'Reilly (75)
  2. Saad Usmani (75)
  3. Edward Christopher Dee (70)
  4. Nadeem Abu-Rustum (70)
  5. Alice Wei (69)
  6. T Peter Kingham (68)

More People

Years
  1. 2024 (5377)
Publications
  1. Journal of Clinical Oncology (521)
  2. International Journal of Radiation Oncology, Biology, Physics (186)
  3. Blood (161)
  4. Annals of Oncology (147)
  5. Annals of Surgical Oncology (131)
  6. Laboratory Investigation (91)

More Publications

Publishers
  1. Elsevier Inc. (784)
  2. American Society of Clinical Oncology (580)
  3. Nature Publishing Group (384)
  4. Springer (357)
  5. Oxford University Press (347)
  6. Elsevier Science, Inc. (256)

More Publishers

Results (5377)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 Study of the Cd40 agonistic monoclonal antibody APX005M (sotigalimab) in pediatric, adolescent, and young adult patients with recurrent or progressive CNS tumors and newly diagnosed brain stem glioma: A Pediatric Brain Tumor Consortium study (PBTC-051; NCT03389802)
    Meeting Abstract

    Lindsay, H. B.; Billups, C.; Baxter, P.; Hwang, E.; Lenzen, A.; MacDonald, T.; Pollack, I. F.; Robison, N.; Vinitsky, A.; Poussaint, T. Y.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST)
    Meeting Abstract

    de la Fuente, M.; Butowski, N. A.; Taylor, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Allen, C. E.; Ammakkanavar, N.; Michelson, G.; Jiang, P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Pilot study to evaluate automated laboratory data transfer into Medidata Rave across the National Cancer Institute (NCI)-supported Pediatric Brain Tumor Consortium (PBTC) and Pediatric Early Phase Clinical Trial Network (PEP-CTN) cooperative groups
    Meeting Abstract

    Miler, T. P.; Aplenc, R.; Minard, C.; Lensing, S.; Wang, Y.; Velamuru, P.; Foster, J. H.; Silverman, M.; Sung, C.; Wong, K.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Medical and surgical variables associated with relapse in central nervous system (CNS) nongerminomatous germ cell tumors (NGGCTS): Secondary analysis of stratum 1 of the Children's Oncology Group ACNS1123 phase 2 clinical trial
    Meeting Abstract

    Nagabushan, S.; Yan, R.; Lin, T.; Onar-Thomas, A.; Souweidane, M. M.; Dhall, G.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program
    Meeting Abstract

    Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Lessons learned from longitudinal care in posterior fossa syndrome
    Meeting Abstract

    Tsetlina, V.; Cassidy, D.; Tenaglia, A. L.; Levin, J.; Tsao, E.; Ibanez, K.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Isocitrate dehydrogenase 1 inhibition primes group-3 medulloblastomas for cuproptosis
    Meeting Abstract

    Dang, D.; McKolay, J.; Smith, K.; Panwalkar, P.; Sweha, S.; Natarajan, S. K.; Pun, M. J.; Ji, S.; Patel, D.; Animasahun, O.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045)
    Meeting Abstract

    Hwang, E. I.; Kilburn, L. B.; Mitchell, D. A.; Lin, T.; Young-Poussaint, T.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and molecular features of high-grade glioma in children and adults with neurofibromatosis type 1: A preliminary analysis
    Meeting Abstract

    Kotch, C.; Solomon, D. A.; Wallace, K.; de Blank, P. M.; Li, Y.; Mbonglou, F.; Reddy, A. T.; Gutmann, D. H.; Piotrowski, A. F.; Fisher, M. J.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Multi-institution analysis of treatment matching status and outcomes in pediatric CNS tumor patients
    Meeting Abstract

    Horowitz, E. J.; Parisi, R.; Rood, G.; Bowden, A.; Byrwa, D.; Patel, R.; Turco, G.; Korones, D.; Andolina, J.; Comito, M.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save